Clinical Trial Update: Study of Everolimus and Sorafenib in Patients With Advanced Thyroid Cancer Who Progressed on Sorafenib Alone [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the combination of everolimus and sorafenib in differentiated thyroid cancer patients who progressed on sorafenib alone.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Differentiated Thyroid Cancer

Drugs mentioned

• Everolimus (everolimus)
• Sorafenib (Sorafenib)

Snippet

Sponsor: Thomas Jefferson University | Conditions: Differentiated Thyroid Cancer | Phase 2 | Status: UNKNOWN